🇺🇸

US SEC Filing Intelligence

· daily

Defense Manufacturing Contracts — March 06, 2026

Science and Engineering Services, LLC (SES), a small minority-owned firm, won an $85M full-and-open CBP aircraft contract, with $57.5M outlayed to date, providing clear revenue visibility through 2027 amid heavy subawarding ($69.5M across 22 subs). Firm-fixed-price structure and long execution timeline introduce material cost overrun risks. This underscores small business capabilities in defense aviation, warranting monitoring for CBP follow-on demand.

1 total filings
· daily

DHS Homeland Security Contracts — March 06, 2026

DHS awarded two large firm fixed price delivery orders totaling $230M, signaling sustained investment in ICE investigative IT ($145M to Palantir) and CBP multi-role enforcement aircraft ($85M to SES), both extending performance to 2027 with 60%+ outlays already booked. Bullish for contractors with revenue visibility, but firm fixed price structures amplify execution risks over multi-year horizons. Cross-cutting theme: DHS prioritizing full/open competition for critical enforcement capabilities amid budget-dependent outlays.

2 total filings
· daily

VA Healthcare & Services Contracts — March 06, 2026

VA awarded $790M in firm fixed price delivery orders for healthcare management (92% to Optum/UnitedHealth Group) and IT services (Deloitte), signaling robust demand and revenue visibility through FY26-28. Both via full/open competition to non-small businesses, with Optum's $724M fully obligated but $0 outlayed vs. Deloitte's $41M already spent. Bullish for healthcare services providers, tempered by execution risks in cost-plus dynamics.

2 total filings
· daily

Federal Construction & Infrastructure Contracts — March 06, 2026

Pernix International, LLC, a small business, secured a $365M firm-fixed-price contract from the Department of State for the Lagos New Consulate Compound, providing multi-year revenue visibility through 2027 but exposing it to full cost overrun risks. This sole large award in federal construction highlights small business competitiveness in infrastructure but flags execution vulnerabilities in a high-value, long-duration project. Investors should monitor outlays and progress for confirmation of bullish momentum.

1 total filings
· daily

Federal Professional Services Contracts — March 06, 2026

GSA's three engineering services contracts total $258M obligated with $896M potential (base + options), all at $0 outlay signaling substantial backlog for ManTech ($623M pot.), Ameresco ($174M pot.), and Honeywell ($100M pot.). Long-term durations to 2029-2041 provide revenue visibility amid federal infrastructure focus. All full/open competition awards to non-SB firms highlight established players' dominance; monitor option exercises for ~$638M upside.

3 total filings
· daily

Federal IT & Cybersecurity Contracts — March 06, 2026

Federal IT & Cybersecurity saw $565M in obligated delivery orders across 5 major awards, signaling robust sustainment spending in healthcare (HHS/VA: 42% of value) and security/defense (DHS/Army: 48%). Primes like General Dynamics, Palantir, Leidos, and Deloitte hold multi-year revenue visibility with $1.2B+ potential via options/extensions to 2031. All bullish with low outlays relative to ceilings indicating upside execution.

5 total filings
· daily

New Federal Contractors — March 06, 2026

New federal contract stream reveals $6.62B in obligations dominated by Lockheed Martin's $2.87B NASA space tank award (43% of total), signaling sustained space sector funding despite historical start dates. Bullish signals across 16 contracts highlight growth in nuclear HALEU production (General Matter $900M DOE), healthcare IT (Optum $724M VA, GD $146M HHS), and long-term engineering/IT services via GSA. Risks center on $0 outlays in 12 contracts and firm-fixed-price exposure, but options add $3.3B+ upside potential through 2041.

19 total filings
· daily

Significant Contract Modifications ($10M+) — March 06, 2026

This period's $6.6B in significant contract modifications is dominated by a $2.87B NASA award to Lockheed Martin for space vehicle components, signaling sustained aerospace demand despite historical dates and zero outlays across many contracts. Bullish signals prevail (16/20) in emerging nuclear (HALEU at $900M to General Matter), healthcare IT (Optum $724M VA, GD IT $146M CMS), and federal IT services, with options adding $2B+ potential upside. Risks center on execution delays ($0 outlays common), firm-fixed-price margin pressures, and ended performance periods limiting near-term cash flows.

20 total filings
· daily

Contract Deobligations Alert — March 06, 2026

This $6.6B batch of contract obligations is dominated by a single $2.87B legacy NASA award to Lockheed Martin for space vehicle components, signaling sustained but historical demand in aerospace. Bullish signals prevail (16/20) across IT/services, healthcare, and emerging nuclear energy (HALEU), with multi-year revenues and $2B+ in unexercised options offering upside. Risks center on $0 outlays (prevalent in 70%+ of records) and firm-fixed-price structures exposing contractors to cost overruns amid long performance periods.

20 total filings
· daily

Contract Option Exercises — March 06, 2026

This week's contract exercises reveal $6.6B in obligations dominated by legacy NASA space contracts (e.g., Lockheed Martin $2.87B), signaling sustained U.S. space investment despite historical end dates and $0 outlays. Emerging bullish signals in nuclear fuel (General Matter $900M HALEU) and healthcare IT (Optum $724M VA, General Dynamics $146M HHS) highlight sector growth, with 16/20 bullish amid options upside totaling billions. Risks center on $0 outlays (12 contracts) and firm-fixed-price exposures, but long-term periods to 2041 offer multi-year revenue visibility for primes like Leidos, ManTech, and Deloitte.

20 total filings
· daily

All DOE Contracts — March 06, 2026

General Matter, Inc., a small business, secured a $900M DOE contract (potential $1.135B with options) for domestic HALEU UF6 production capacity, signaling strong U.S. government commitment to advanced nuclear fuels over a 10-year horizon. This positions the company for long-term revenue but carries execution risks under a firm fixed-price structure with no outlays to date. Investors should monitor HALEU sector for supply chain buildup amid nuclear energy resurgence.

1 total filings
· daily

Mega Contracts Monitor ($100M+) — March 06, 2026

This $6.08B batch of mega contracts is dominated by Lockheed Martin's $2.87B NASA space vehicle award (47% of total), underscoring persistent U.S. space spending despite historical timelines. Emerging bullish signals in nuclear energy via General Matter's $900M DOE HALEU production deal and healthcare IT via Optum's $724M VA order highlight growth in strategic sectors. IT/defense primes like Leidos, ManTech, Palantir show $600M+ obligations with $1.4B options potential, though $0 outlays across most signal funding lags; prioritize monitoring option exercises for 50%+ upside.

12 total filings
· daily

High-Value Federal Grants ($5M+) — March 06, 2026

This $6.62B batch of 19 high-value federal contracts (> $5M) yields 16 bullish signals, dominated by legacy NASA space awards to primes like Lockheed Martin ($2.87B) and emerging nuclear energy production (General Matter $900M HALEU). IT/telecom and healthcare services for VA/HHS/DHS show strong multi-year visibility with partial outlays, while firm-fixed pricing and $0 outlays in 12 contracts flag execution risks. Investors should prioritize options upside (~$3B+ potential) in active IT/healthcare deals over historical NASA obligations.

19 total filings
· daily

DOE Energy Grants — March 06, 2026

General Matter, Inc. secured a $900M DOE obligation (potential $1.135B with options) for domestic HALEU UF6 production capacity, marking a major bullish signal for U.S. advanced nuclear fuel supply chain. The 10-year firm-fixed-price contract from 2026-2036 positions this small San Francisco firm for long-term revenue, though with execution risks from cost overruns and zero outlays to date. Investors in nuclear sectors gain a clear opportunity amid DOE's strategic push for HALEU independence.

1 total filings
· daily

General Federal Contracts — March 06, 2026

Federal contracts totaling $6.62B highlight bullish signals dominated by Lockheed Martin's $2.87B NASA space vehicle award (50%+ of value), alongside emerging $900M DOE HALEU production for General Matter and $724M VA healthcare IT for Optum/UnitedHealth. Healthcare IT and gov services show steady multi-year obligations (e.g., General Dynamics $146M CMS, Palantir $145M DHS), with long-term extensions to 2041 possible. Risks center on $0 outlays in 12 contracts and firm-fixed-price exposure, but options add $3B+ potential upside across portfolio.

19 total filings
· daily

All NASA Contracts — March 06, 2026

NASA's four historical contracts totaling $3.41B obligations (84% to Lockheed Martin) highlight trusted incumbents in space vehicle components and support, with bullish signals on Lockheed and Hamilton Sundstrand amid $268M unexercised options. Zero outlays and expired performance periods (2004-2013) across all signal data lags or completion, limiting near-term cash flow relevance. Investors gain insight into NASA's cost-plus preference for non-competitive awards to space primes, warranting parallels to current programs.

4 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — March 06, 2026

Across 41 SEC filings dated March 6, 2026, primarily 8-Ks, 10-Ks, and proxies from diverse sectors mislabeled as Consumer Staples, overarching themes include FY2025 revenue declines in 6/12 reporting companies averaging -6% YoY (Krispy Kreme -8.6%, IMXI -8%, Mammoth -2.9%, ArcelorMittal -1.7%), widening net losses in biotechs (PMV +32% to $77.7M) offset by narrowing in services (Mammoth -65% to $63.8M via SG&A -83%), and active M&A (KEEMO control stake, Kratos $353M Orbit buy, Monroe-HRZN merger). Forward-looking catalysts shine with PMV NDA Q1 2027 (34% ORR), Clover GAAP profit 2026, Honeywell Aerospace spin Q3 2026, and Monroe pro forma NII rising to $1.24 by 2030. Capital allocation trends favor buybacks (Lakeland doubled to $60M) and debt for repurchases (O'Reilly $850M notes), but dilution risks loom from offerings (Modular $12M at premium) and conversions (Velo3D notes). Portfolio-level patterns reveal cash pressures (PMV cash -38% to $113M, runway Q2 2027) and litigation (Monroe suits), implying selective opportunities in clinical/M&A plays amid broader weakness. Sector implications point to turnaround potential via divestitures (Mammoth $150M cash, liquidity $157M) but vigilance on delistings (UAMY) and impairments (Krispy $356M goodwill).

25 high priority 16 medium 41 total filings
· daily

S&P 500 Industrials Sector SEC Filings — March 06, 2026

Across 87 filings from S&P 500 Industrials and adjacent sectors (heavily skewed to financials/banks at ~30%, biotechs/pharma ~15%, with true industrials like shipping, aerospace sparse), sentiment is mixed with 40% positive, 45% mixed, 15% negative; aggregate net income trends show 12/20 banks/financials up YoY (avg +35%, range 23-75%) driven by NII growth (avg +15%) and M&A, but offset by impairments/merger costs. Revenue growth strong in growth names (e.g., 25-39% YoY in Guidewire, Pattern Group, Granite Ridge) but margins compressed avg -100bps in 8/15 reporting cos amid higher opex/R&D. Key developments include M&A acceleration (Kratos Orbit $353M, Day One $2.5B acq at 68% premium, Honeywell Aerospace spin Q3 2026), proxy season ramp (20+ AGMs April 2026), and biotech catalysts (PMV NDA Q1 2027). Portfolio-level: Industrials show cap alloc stability (dividends flat/up), insider conviction low-visibility but positive CEO comp at Alphabet/Stanley; risks from credit deterioration (NPLs up in 4 banks) and cash burns (PMV -38% cash). Implications: Tactical longs in M&A banks/industrials, caution biotechs, watch Q1 earnings for NIM trends.

56 high priority 31 medium 87 total filings
· daily

S&P 500 Energy Sector SEC Filings — March 06, 2026

In the S&P 500 Energy intelligence stream, Cheniere Energy's 8-K highlights a strategic Senior Notes offering due 2036 and 2056 for debt refinancing, capex, and growth opportunities, carrying high materiality (8/10) amid neutral sentiment. Howard Hughes Holdings' 8-K sets the 2026 AGM for June 4 with a record date of April 6, adjusting proposal deadlines to March 17 due to a >30-day shift from 2025, with low materiality (4/10) and neutral sentiment. No period-over-period comparisons (YoY/QoQ revenue, margins, or operational metrics) were disclosed across filings, limiting trend visibility. Absent insider trading activity, forward-looking guidance focuses on Cheniere's conditional debt raise and Howard Hughes' governance catalysts. Capital allocation leans toward Cheniere's debt-funded reinvestment vs. Howard Hughes' shareholder engagement timeline. Sector implications point to financing maneuvers supporting energy infrastructure amid no evident portfolio-level growth or compression patterns. Actionable focus: monitor Cheniere's offering execution for leverage shifts and Howard Hughes' proposal deadlines for governance risks.

1 high priority 1 medium 2 total filings